MaxCyte, Inc. Capital Expenditures
MaxCyte, Inc. (MXCT) reported Capital Expenditures of $134.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- MaxCyte, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $62.00K, a 89.38% decline year-over-year.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $72.00K, a 88.97% decline year-over-year.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $231.00K, a 57.14% increase year-over-year.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $300.00K, a 26.11% decline year-over-year.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.77M, a 7.09% increase from fiscal 2024.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.65M, a 55.38% decline from fiscal 2023.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $3.70M, a 79.98% decline from fiscal 2022.
- MaxCyte, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $18.48M, a 381.90% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $134.00K 10-Q · filed 2026-08-13 | $365.00K derived: sum of 3 quarters · filed 2026-08-13 | $665.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $72.00K 10-Q · filed 2026-05-13 | $303.00K derived: sum of 2 quarters · filed 2026-05-13 | $603.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.19M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $531.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.11M derived: sum of 3 quarters · filed 2026-08-13 | $1.77M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $884.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.54M 10-Q · filed 2025-11-13 | $1.68M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $584.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.24M 10-Q · filed 2026-08-13 | $1.38M derived: sum of 3 quarters · filed 2026-08-13 | $1.79M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $653.00K 10-Q · filed 2026-05-13 | $800.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.21M derived: sum of 3 quarters · filed 2026-05-13 | $1.50M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $553.00K derived: sum of 2 quarters · filed 2026-03-25 | $847.00K derived: sum of 3 quarters · filed 2026-03-25 | $1.65M 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $700.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.50M 10-Q · filed 2025-11-13 | $2.42M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.10M 10-Q · filed 2025-08-06 | $2.01M derived: sum of 3 quarters · filed 2025-08-06 | $2.73M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $804.00K 10-Q · filed 2025-05-08 | $1.72M derived: sum of 2 quarters · filed 2025-05-08 | $2.44M derived: sum of 3 quarters · filed 2025-05-08 | $2.95M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.64M derived: sum of 2 quarters · filed 2025-03-11 | $2.14M derived: sum of 3 quarters · filed 2025-03-11 | $3.70M 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.23M derived: sum of 2 quarters · filed 2024-11-06 | $2.79M 10-Q · filed 2024-11-06 | $2.79M 10-Q · filed 2023-11-08 | $4.98M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $507.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.06M 10-Q · filed 2024-08-06 | $4.26M derived: sum of 3 quarters · filed 2024-08-06 | $7.74M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $1.56M 10-Q · filed 2024-05-07 | $3.75M derived: sum of 2 quarters · filed 2024-05-07 | $7.23M derived: sum of 3 quarters · filed 2024-05-07 | $14.04M derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $5.67M derived: sum of 2 quarters · filed 2024-03-12 | $12.48M derived: sum of 3 quarters · filed 2024-03-12 | $18.48M 10-K · filed 2024-03-12 | $18.48M 10-K · filed 2023-03-15 | |
| 2022-09-30 | $3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.28M derived: sum of 2 quarters · filed 2023-11-08 | $16.28M 10-Q · filed 2023-11-08 | $17.40M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $6.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $12.80M 10-Q · filed 2023-08-09 | $13.93M derived: sum of 3 quarters · filed 2023-08-09 | $15.37M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $6.00M 10-Q · filed 2023-05-10 | $7.12M derived: sum of 2 quarters · filed 2023-05-10 | $8.56M derived: sum of 3 quarters · filed 2023-05-10 | $9.53M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.56M derived: sum of 2 quarters · filed 2023-03-15 | $3.53M derived: sum of 3 quarters · filed 2023-03-15 | $3.83M 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.40M derived: sum of 2 quarters · filed 2022-11-09 | $2.71M 10-Q · filed 2022-11-09 | $3.07M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $962.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.27M 10-Q · filed 2022-08-10 | $1.63M derived: sum of 3 quarters · filed 2022-08-10 | $2.29M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $308.50K 10-Q · filed 2022-05-09 | $667.30K derived: sum of 2 quarters · filed 2022-05-09 | $1.33M derived: sum of 3 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $358.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.02M derived: sum of 2 quarters · filed 2022-03-22 | $2.07M 10-K · filed 2022-03-22 | |||
| 2020-09-30 | $663.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.71M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $1.05M 10-Q · filed 2021-09-13 | |||||
| 2019-12-31 | $1.27M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |